Last remaining trial for Aveo's lead cancer drug cancelled

The future of a drug that was once the most promising treatment to be developed by Aveo Oncology is in doubt after the company said that its last remaining trial has been canceled due to insufficient enrollment.

http://ift.tt/1fu0ZAp